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1INTRODUCTION
          The laryngeal mask airway has gained recognition as an acceptable
device for securing the airway of patients during anaesthesia and
emergency airway management within the hospital environment.
Furthermore, the LMA has been utilized by paramedics in the pre-
hospital setting when endotracheal intubation is either unavailable
(untrained personnel) or impossible (failed intubation).
The LMA revolutionized the anaesthetic practice and has now been
used in more than 80 countries throughout the world .the LMA has been
widely accepted as a form of airway management in the pre-hospital
environment and inexperienced personnel. It has been shown that
insertion of the LMA is easier and is less likely to produce gastric
insufflations , a common problem with face mask ventilation. The LMA
has now been referred to as gold standard of supraglottic devices.
The inventor of the “classic LMA” , Dr Archie Brain ,devised the
airway to provide an alternative to the face mask ventilation. The LMA
offers a relatively “hand-free’ airway that does not require laryngoscopy
for insertion and thereby minimizing laryngeal trauma and unwanted
laryngeal reflexes.
For these reasons, the LMA is endorsed by the Australian
resuscitation council and The American Society Of Anaesthesiologists as
2rescue airway, and as a first line airway management device in those with
limited airway management experience.
It does not provide airway protection in full stomach patients and it
increases chances of aspiration. To overcome the above complications Dr
Archie Brain designed the Pro-seal LMA in 2000,with modification
designed to enable separation of GIT and respiratory tract, to improve
airway seal, to enable positive pressure ventilation and diagnose mask
displacement. A drainage tube enables diagnosis of mask displacement;
reduce the risk of gastric insufflations, regurgitation and aspiration of
gastric content.
I-gel is a new supraglotic device .I-gel has successfully combined
the concept of non cuffed supraglottic device like SLIPA and the gastric
tube  of  the  ProSeal  LMA,  yet  retaining  the  shape  LMA.  This  will  also,
reduce the risk of gastric insufflations, regurgitation and aspiration of
gastric contents.
With this background this study was conceptualized to compare clinical
performance of I-gel and ProSeal LMA in elective gynecological
surgeries.
3AIMS AND OBJECTIVES
The purpose of this study was to prospectively compare the clinical
performance of the two supraglottic airway devices, PROSEAL LMA
AND IGEL in elective surgeries in terms of the following parameters.
1. Ease of insertion
2. No. of insertion attempts
3. Time taken for insertion
4. Hemodynamic responses
5. Blood staining of devices
6. Incidence of complication
STRUCTURE AND FUNCTION
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4STRUCTURE AND FUNCTION OF THE UPPER AIRWAYS10
Anatomically airway is the passage through which the air passes
during respiration. It may be divided into upper and lower airway. The
upper airway comprises nasal cavity, oral cavity, nasopharynx,
oropharynx, pharynx and larynx.
Nasal cavity:
Nasal cavity extends form nares to end of the turbinates. The
normal airway begins functionally at the nares. As air passes through the
nose, the important functions of warming and humidification occur. The
nose is the primary pathway of normal breathing. The nasal cavities are
divided by nasal septum. The roof is formed by cribriform plate of the
ethmoid bone. The bony lateral wall is the origin of the three bony
turbinates that project into the nasal cavity. Openings in the lateral wall
communicate with paranasal sinuses.
Oral cavity:
It extends from mouth opening to anterior tonsillar pillar.
Contracture of mouth and lips can lead to difficult laryngoscopy. The roof
of the mouth is bounded by alveolar arch and teeth and consist of the hard
palate anteriorly and soft palate posteriorly. The tongue makes up  most
of the mouth, which is bounded by the mandible and teeth. The ability to
5achieve good mouth opening is important for many airway procedures.
Initial mouth opening is  achieved by rotation within the
temperomandibular joint and subsequent opening by sliding of the
condyles of the mandible within the joint.
Pharynx:
The Pharynx is a fibromuscular tube that extends from the base of
the  skull  to  the  lower  border  of  cricoid  cartilage.  It  joins  the  nasal  and
oral cavities above; with larynx and esophageus below. It is divided into
nasopharynx and oropharynx.
The nasopharynx:
Extends from the posterior end of turbinates to posterior
pharyngeal  wall  above  the  soft  palate  and  consist  of  the  nasal  cavity,
septum, turbinates and adenoids.
The oropharynx:
Extends from the soft palate above and epiglottis below; and
anteriorly from tonsillar pillar to posterior pharyngeal wall. It includes the
tonsils, uvula and the epiglottis. The tongue is the principal source of
oropharyngeal construction, usually because of decreased tone of the
genioglossus muscle. The latter contracts to move the tongue forward
during inspiration and thus acts as a pharyngeal dilator. The vallecula is
6the space between epiglottis and base of the tongue. It has paired
depressions on both sides of glosso epiglottic fold.
Laryngoscope blade tip is positioned in vallecula during
conventional laryngoscopy. Gentle upward pressure on the vallecula with
laryngoscope blade tensions hyoepiglottic ligament and indirectly
elevates the larynx and helps in the alignment of laryngeal and
pharyngeal axes.
Larynx:
The larynx, which lies at the level of the third through sixth
cervical vertebrae, serves as the organ of phonation and as a valve to
protect the lower airways from the contents of the alimentary tract.
The laryngeal cavity extends from the epiglottis to the lower level
of the cricoids cartilage. The larynx bulges posteriorly into the
laryngopharynx, with the pyriform fossa lying on each side. It is
suspended from the hyoid bone by the thyrohyoid membrane.
The structure consists of muscles, ligaments, and a framework of
cartilages. These include the thyroid, cricoids, arytenoids, corniculates,
and the epiglottis. The latter, a fibrous cartilage, has a mucous membrane
covering that reflects as the glossoepiglottic fold onto the pharyngeal
surface  of  the  tongue.  The  epiglottis  projects  into  the  pharynx  and
ANATOMY & NERVE  SUPPLY  OF  LARYNX
7overhangs the laryngeal inlet. However, it is not absolutely essential for
sealing off the airway during swallowing.
The inlet is formed by the epiglottis, which joints to the apex of the
arytenoid cartilages on each side by the aryepiglottic folds. Inside the
laryngeal cavity one first encounters the vestibular folds, which are
narrow bands of fibrous tissue on each side. These extend from the
anterolateral surface of each arytenoids to the angle of the thyroid where
the latter attaches to the epiglottis. These folds are referred to as the false
vocal cords and are separated from the true vocal cords by the laryngeal
sinus or ventricle.
The true vocal cords are pale white ligamentous structures that
attach to the angles of the thyroid anteriorly and to the arytenoids
posteriorly. The triangular fissure between these vocal cords is termed the
glottis opening, which represents the narrowest segment of the laryngeal
opening in adults.
Cricoid cartilage is a complete ring shaped cartilage and continues
with trachea. In young children (<10 years old), the narrowest segment
lies just below the cords at the level of the cricoid ring.
8LARYNGEAL MASK AIRWAY
CONCEPTS AND DESIGNS OF LMA
The LMA fills a niche between the face mask and tracheal tube in
terms of both anatomical position and degree of invasiveness. It is
manufactured from medical grade silicone rubber and is reusable. It
consists of 3 main components – Airway  tube, inflatable masks and mask
inflation line .
The airway tube is slightly curved to match the oropharyngeal
anatomy, semi rigid to facilitate atraumatic insertion and semi
transparent, so that condensation and regurgitated material is visible. A
black line runs longitudinally along its posterior curvature to aid in
insertion.
The distal inflatable mask is protected by two flexible vertical
rubber bars, called mask aperture bars, to prevent the epiglottis from
entering and obstructing the airway. The inflatable mask is oval shaped
with a broad, round proximal end and a narrower, more pointed distal
end. It has an inflatable cuff and a semi rigid, concave, shield like back
plate.
The inner aspect of the mask is called the bowl, which is comprised
of the distal aperture, mask aperture bars, back plate and the inner aspect
9of  the  inflatable  cuff.  The  LMA  consists  of  a  curved  tube  (shaft)
connected to an elliptical spoon shaped mask at an angle of thirty (30)
degrees.
At the machine end of the tube is a standard 15mm connector
There are 7 available sizes. The selection of size is according to the
body weight of the patient and cuff volume is specified for each size,
shown in the following table
Mask size Body weight (kg) Maximum inflation volume
(ml)
1 < 5 4
1 5 – 10 7
2 10 – 20 10
2.5 20 – 30 14
3 30 – 50 20
4 50 – 70 30
5 > 70 40
INDICATIONS OF LMA
1. LMA is used for securing patient’s airway during general
anaesthesia as an alternative to endotracheal tube or face mask
2. LMA is useful in patients where maintenance of airway with mask
is difficult such as edentulous patients, facial injury, burns
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3. In case of inability to intubate or ventilate LMA may be life saving
either as primary means of securing patient’s airway or to facilitate
passage of ET tube
4. LMA can be used for  diagnostic bronchoscopy as an excellent aid
to laryngeal inlet
5. During CPR, for rapid securing of patient’s airway, LMA can be
used
CONTRAINDICATIONS :
1. Patients with full stomach
2. Patients with hiatus hernia unless effective measures have been
taken to empty the stomach
3. Patients with fixed reduced pulmonary compliance such as
pulmonary fibrosis
4. Oral, perioral pathology such as tumour, abscess, grossly enlarged
tonsil
5. Mouth opening less than 2cms
ADVANTAGES OF LMA OVER ENDOTRACHEAL TUBES:
1. Rapid and easy access of airway
2. Laryngoscopy and muscle relaxants are not required
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1. Hemodynamics and intraocular pressure changes are less than
endotracheal tube intubation
2. Tolerance is better and LMA is less likely to cause injury to the
airway than endotracheal tube
3. Minimal stimulation if left in situ until protective airway reflexes are
recovered
ADVANTAGES OF LMA OVER FACE MASK :
1. It is easier to obtain air tight seal with LMA when a good seal with
face mask is difficult
2. The anaesthesiologist’s hands are free and does not require jaw
support
DISADVANTAGES OF LARYNGEAL MASK AIRWAY:
1. Patient with glottis or subglottic obstruction cannot be managed with
LMA
2. Appropriate size LMA should be used. Larger or smaller size LMA
will result in improper seating, leading to cuff leak or airway
obstruction due to trapping of epiglottis
12
1. The airway is not protected. Hence LMA is not to be used in
patients with full stomach
TYPES OF LMA
? Reinforced / flexible LMA (LMA – flexible)
? LMA specifically designed for tracheal intubation (LMA –
Fastrach)
? Intubating LMA with real time visualization of larynx (LMA-
C Trach)
? Single – use LMA (LMA – Unique)
? LMA with an integral gastric access venting port (LMA –
Proseal)
13
PROSEAL LMA9
The Proseal laryngeal mask airway was designed and developed by
Dr.Archie Brain in late 1990, with a primary goal to construct a laryngeal
mask with improved ventilatory characteristics and that also offered
protection against regurgitation and gastric insufflations.
DEVICE DESCRIPTION:
The Proseal LMA is made from medical grade silicone and is reusable. It
has four main components
1. Mask
2. inflation line with pilot balloon
3. Airway tube
4. Drain tube
The cuff of the mask has identical proportions but different
dimensions amongst sizes.
Modified Feature Intended Purpose
1) The second cuff attached to
dorsal surface
To improve seal by pushing the
ventral cuff
2) The ventral cuff that is larger
proximally
To form a better seal by plugging
gaps in the proximal pharynx
To reduce the risk of down folded
epiglottis obstructing the distal
aperture
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3) A large conical shaped distal
Cuff
To form a better seal with the
hypopharynx.
To reduce the risk of down folded
epiglottis obstructing the distal
aperture
4) A parallel, narrow – bore,
double tube configuration
To increase stability
To improve seal by allowing the
tongue to form a more effective plug
5) A flexible, wire reinforced
airway tube
To prevent airway tube from kinking
6) A drainage channel To facilitate gastric tube insertion
To divert regurgitated fluid away
from the respiratory tract.
To prevent gastric insufflation
7) A drainage tube distal aperture
that is sloped anteriorly
To allow the deflated tip to form a
fine edge for insertion
8) A plastic supporting ring
around the distal drainage tube
To prevent the drainage tube from
collapsing when the cuff is inflated
9) Drainage tube that passes
within the bowel
To avoid altering the external shape
of the cuff
To function as mark aperture bar for
accessory vent
10) A rectangular depression in
the proximal bowel tube
To function as an accessory
ventilation channel
To prevent pooling of secretions at
the distal aperture of the airway
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11) Built – in – bite block To prevent airway obstruction
To prevent damage to the device
during biting
To provide information about depth
of insertion
To help fuse airway and drainage
tube together
12) Introducer strap To prevent finger from slipping off
the tube
To keep proximal cuff in the midline
13) No back plate To reduce and allow room for the
dorsal cuff
14) No mask aperture bar To reduce resistance to gas flow
SIZES AVAILABLE
Proseal
LMA
size
Patient
selection
Guidelines
Proseal
LMA
airway tube
ID(mm)
Maximum
cuff
inflation
Volume
(Air)
Gastric
Tube
ETT FO
D
1 ½ 5 – 10 kg 6.4 7ml 10 Fr 4.5 3.5
2 10 – 20 kg 6.4 10ml 10 Fr 4.5 3.5
2 ½ 20 – 30 kg 8.0 14ml 14 Fr 4.5 3.5
3 30 – 50 kg 9.0 20ml 16 Fr 5.0 4.0
4 50 – 70 kg 9.0 30ml 16 Fr 5.0 4.0
5 70 – 100 kg 10.0 40ml 18 Fr 5.0 4.0
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These are maximum volumes that should never be exceeded. It is
recommended that the intracuff pressure should not exceed 60cm H2O.
Protocol for PLMA Use:
Preparation of Use :
With proper cleaning, sterilization and handling, the proseal LMA
can be safely used 40 times
CLEANING :
It is washed in warm water and dilute (8 -10% w/w) sodium
bicarbonate solution until all visible foreign matter is removed. Clean the
tubes using a small soft bristle brush. Thoroughly rinse the cuff, airway
tube and drain tube in warm, flowing tap water to remove cleaning
residues. Care should be taken to ensure that water does not enter the
device through the valve.
STERILIZATION :
Steam autoclaving is the only recommended method for
sterilization of the proseal LMA. Immediately prior to steam autoclaving,
deflate the cuff, pulling the syringe backwards to obtain a high vaccum.
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The maximum temperature should not exceed 1350 C or 2750 F.
The proseal LMA introducer  and cuff deflator should be cleaned and
sterilized in the same manner.
PERFORMANCE TESTS :
Non – clinical tests must be conducted before each use of the
device. These include,
1. Visual inspection :
Ensure that the thin- walled section of the drain tube lying within
the mask bowl is not torn or perforated. Do not use the proseal LMA if
the tubes are discoloured as this impairs the ability to see foreign particles
or regurgitated fluids. Examine the surface of the device for damage.
2. Inflation and deflation :
Using a syringe fully deflate the device so that the cuff walls are
tightly flattened against each other. Do not use if the cuff walls re-inflate
immediately and spontaneously
INDEX FINGER INSERTION TECHNIQUE
? Finger insertion technique is not recommended for proseal LMA
sizes 1 ½ - 2 1/2 . These sizes have a dedicated introducer
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? Hold the proseal LMA like a pen with the index finger pushed into
the introducer step
? Under direct vision, press tip of the cuff upwards against the hard
palate and flatten the cuff against it.
? As the index finger passes further into the mouth finger, joint
begins to extend
? The jaws should not be held widely open
? Push the downwards with middle finger or instruct the assistant to
pull lower jaw downwards momentarily using the index finger to
guide the device, press downwards towards the other hand,
exerting counter pressure
? Advance the device into hypopharynx until a definite resistance is
felt. Full insertion is not possible unless the finger is fully extended
and wrist is fully flexed
? Before removing the finger, the non dominant hand is brought from
behind the patients head to press down on the airway tube
? This prevents the device from being pulled out of place when the
finger is removed. It also permits completion of insertion in the
event that this has not been achieved by the index finger alone. At
this point the proseal LMA should be correctly located with its tip
firmly pressed up against the upper oesophageal sphincter. Remove
the finger
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DEVICE INFLATION
After insertion, the tubes should emerge from the mouth directed
caudally. Without holding the tubes, inflate the cuff with just enough air
to obtain an intracuff pressure equivalent to approximately 60cm H2O.
During cuff inflation, do not hold the tube as this prevents the mask from
settling into its correct location.
The signs of correct placement may include one or more of the
following
? Slight outward movement of tube upon inflation
? Presence of smooth oval swelling in the neck around the thyroid
and cricoid area. Never over inflate the cuff
? Expansion of the chest wall on bag compression
? The conformation of the correct placement by square wave pattern
in capnography.
DEVICE FIXATION :
Once inflated, the device should be fixed in place with fish mouth
taping (maxilla to maxilla. While fixing, ensure that the tip of the mask is
pressed securely against the upper oesophageal sphincter. Correct fixation
is more critical for PLMA because any migration proximally of the tip
from hypopharynx will result in air leakage up the DT during IPPV.
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OROGASTRIC TUBE INSERTION :
The primary function of the drain tube is to provide a separate
conduit from and to the alimentary tract. This is then passed down the DT
of PLMA without any haste or force. A slight resistance is normal felt as
the tip passes against upper oesophageal sphincter.
There is an inherent resistance to gastric tube insertion after 23cm
of passage due to angulation of 90 in the passage of DT to its tip. There
may be difficulty in passing gastric tube due to following reasons
1. Selection of too large gastric tube
2. Inadequate lubrication
3. Use of cooled gastric tube
4. Cuff over inflation
5. Malposition of PLMA
The advantages of inserting gastric tube are
1. It allows removal of gas or fluid from the stomach
2. Confirm position / Patency of drainage tube
3. Functions as a guide to PLMA insertion if accidental displacement
occurs
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The disadvantages of inserting gastric tube are
1. Risk of tracheal placement
2. Oesophageal perforation rarely
3. The presence of gastric tube may trigger regurgitation by
interfering with oesophageal sphincter function
4. Gastric tube blocks drainage tube so that gas and fluid cannot
escape from oesophagus
22
I –GEL
I – gel is the new Supraglottic airway device developed by
Intersurgical Ltd., (Workingham, Berkshire, UK). It is made up of
medical grade thermoplastic elastomer, which is soft, gel like transparent
& designed to anatomically fit the perilaryngeal & hypopharyngeal
structures without an inflatable cuff. It is said to have easier insertion,
minimal risk of tissue compression & stability. It is latex free supraglottic
device. It is available in seven variable sizes 1, 1.5, 2, 2.5, 3, 4, 5.
KEY COMPONENTS AND THEIR FUNCTION
1. Soft non inflatable cuff
The novel soft noninflatable cuff fits snuggly on to the
perilaryngeal framework. The tip lies in the proximal opening of the
esophagus isolating theesophageal opening from the laryngeal inlet. The
outer cuff shape ensures that the blood flow to the laryngeal and
perilaryngeal framework is maintained and helps to reduce the possibility
of neurovascular compression.
2. Gastric channel
The gastric channelruns through a device from its proximal
opening at the side of the flat connector wing to the distal tip of the non
inflatable cuff. Since the distal part of the device fits snuggly and
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anatomically correctly into the upper esophageal opening. The distal
opening of the gastric channel allows for the passing of a nasogastric tube
to empty the stomach contents and can facilitate the venting of the gas
from stomach. The size one I gel does not have gastric channel
3. Epiglottic rest
An artificial epiglottis and a protective ridge help prevent the
epiglottis from downfolding or obstructing a distal opening of the airway
4. Buccal cavity stabilizer
The buccal cavity stabilizer has a built in natural curvature and an
inherent propensity to adapt its shape to the oropharyngeal curvature of
the patient. It is anatomically widened and concaved to eliminate the
potential for rotation, thereby reducing the risk of mal rotation.
5. 15mm connector
To provide a standard 15mm connection to the anaesthetic system.
A port of entry for gastric channel – the port is independent of the
main 15 mm connection and is located  on the right side of the connector
wing
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Integral bite block – this function is provided by the distal part of
the  connector  which  runs  through  the  centre  of  the  proximal  part  of  the
buccal cavity stabilizer
As a guide to correct positioning – the integral part of the bite
block is marked with a horizontally placed black line which signifies the
optimum position of the teeth while the device is in situ
INSERTION TECHNIQUE
1. The patient should be in the sniffing position . The chin should be
gently pressed down before proceeding to insert I gel
2. Grasp the lubricated I gel firmly along the integral bite block.
Position the device so that I gel cuff outlet is facing towards the
chin of the patient
3. Introduce the leading soft tip into the mouth of the patient in a
direction towards the hard palate.
4. Glide the device downwards and backwards along the hard palate
with a continuous but gentle push until a definitive resistance is
felt.
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5. At this point the tip of the airway should be located into the upper
esophageal opening and the cuff should be located against the
laryngeal framework. The incisors should be resting on the integral
bite block
6. The I gel should be taped down from maxilla to maxilla
7. An appropriate size nasogastric tube passed down the gastric
channel.
26
REVIEW OF LITERATURE
ISHWAR SINGH, MONIKA GUPTA, MANSI TANDON1
(Indian journal of anaesthesia 2009:53(3):302-305)
          They compared I gel and proseal LMA in elective surgeries. They
assessed the airway sealing pressure, ease of insertion ,success rate of
insertion, use of gastric tube placement , airway trauma by post operative
blood staining of the device ,tongue, lip, and dental trauma, hoarseness
,regurgitation-aspiration and cost effectiveness.
           They found airway sealing pressure was higher with group p(29.6
CM H2O) than group i(25.27 CM H2O (p<0.05))  but  the  airway  sealing
pressure of group I was very well within the normal limit to prevent the
aspiration.  The ease of insertion was more with group I(29/30) than with
group p(25/30) the success rate of first attempt of insertion and ease of
gastric tube placement was more with group I(p>0.05).blood staining of
device and tongue lip dental trauma was more with group p(p>0.05).
there was no evidence of bronchospasm, laryngospasm, regurgitation,
aspiration or hoarseness in either group.
J.J GATWARD, T.M.COOK, C.SELLER
(Anaesthesia , 2008,63 pages 1124-1130).
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They studied the I-GEL in 100 elective, anaesthesised patients (55
male, 45 female, median age is 53 years) assessing ease of use, airway
quality, positioning, seal and complications. First insertion attempts was
successful in 86 patients, second attempt  in 11 patients, third attempt in 3
patients. 53 manipulations were required 26 patients to achieve aclear
airway. Median insertion time was 15 seconds. During ventilation expired
tidal volume of 7 ml per kg  was achieved in 96 patients. Median airway
leak pressure was 24 CM H2 O on fibro optic examination via the device
vocal cord were visible in 87 patients. There one episode of regurgitation
without aspiration. They found I-GEL was easily and rapidly inserted,
providing a reliable airway in over 90% of patients.
V.UPPAL , S.GANGAIAH, G.FLECTHER AND
J.KINSELLA
(British journal  of anaesthesia 2009 feb :102(2):264-8)
They compared I-GEL and LMA in anaesthetized, paralyed adults.
They assessed airway leak pressure, time to insertion, the number of
insetion, and reposition attempts, leak volumes and leak fractions. They
found there was no signifigance difference between the airway leak
pressure of the two devices I-GEL and LMA respectively. The median
insertion time for the I-GEL was signifigantly lesser than LMA-U. all the
LMA-U devices 38 of 39 I-GEL airways wered inserted at the first
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attempt. The number of manipulations required after insertion to scheive
a clear airway was the same in both the groups(four in each). There were
no statistically significant differences in leak volumes or leak fractions
during controlled ventilation.
             They found no difference in leak pressures and success rate of
first time insertion between the I-GEL and the LMA-U. time to successful
insertion was significantly shorter for the I-GEL. They concluded that the
I-GEL provides a reasonable alternative to the LMA-U for controlled
ventilation.
SHIN.WJ, CHEONG YS. YANG HS17
European Journal of Anaesthesia 2009 Nov. 12
They compared IGEL, proseal LMA and classic LMA in
anaesthetized patient. They assessed hemodynamic data, airway leak
pressure, Leak volume, success rate and post operative complication.
They found there were no difference in the demographic data and
hemodynamic data immediately after insertion of the devices among
three groups. The airway Leak pressure of the IGEL group (27.1+ 6.4cm
H20) and PLMA group (29.8 + 5.7cm H2O) were significantly higher than
that of the cLMA group (24.7 + 6.2cm H2O) the success rate of insertion
were similar among the three groups (P = 0.670).
29
 There were no difference in the incidence of adverse events except for
the large incidence of sorethroat in cLMA group. They concluded IGEL
may  have  a  similar  airway  sealing  to  that  of  PLMA  higher  than  that  of
cLMA and not associated with adverse events.
HOHLRIEDER M, BRIMACOMBE J, VON GOEDECKE A13,
KELLER C et al IN 2007
Assessed postoperative nausea, vomiting, airway morbidity and
analgesic requirements for PLMA and ETT in 200 female patients, ASA I
& II, aged 18 – 75 yrs undergoing breast and gynaecological surgery.
Ventilation was better and airway trauma less frequent for PLMA.
For PLMA time spent in postoperative care unit was shorter (69 Vs 88 mt
P<0.001). Few doses of tropisetron (P < or =0.001) required in
postoperative care unit. Nausea was less frequent at all times (Over all
13% Vs 53%, P = 0.001) vomiting was less frequent at 2 hrs (4% Vs 18%
P = 0.003) and 24 hrs (5% Vs 19%, P = 0.004) and sorethroat was less
frequent at all times (Over all 12% Vs 38% P < 0.0001).
           They concluded that the frequency of postoperative nausea,
vomiting, airway morbidity and analgesic requirements are lower for
PLMA when compared to endotracheal tube.
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MILLER DM, COMPOROTA L14, et al IN 2006
Compared the efficacy of PLMA and SLIPA supra laryngeal
airways (SLA) with standard tracheal tube in 150 patient undergoing day
care laparoscopic gynaecological surgery requiring general anaesthesia.
              An identical GA technique was used in all patients apart from
addition of muscle relaxants and reversal drugs in ETT group. Ease of
use, quality of seal, ventilation, systolic pressure, response to intubation,
side effects and operating room time were assessed.
               Both PLMA and SLIPA were easy to insert (100% success) and
ventilation with respective maximum sealing pressures of 31 and 30 cm
H2O (P = 0.4) with no muscle relaxants. The seal quality is both PLMA
and SLIPA permitted the use of low flows, 485 (291) and 539 (344) ml x
min (-1) (P = 0.2) respectively, although in the ETT group significantly
lower flows (377 (124 ml x min (-1) (P < 0.01) were achieved.
             Systolic pressure in the SLA group was more stable in response
to insertion than in ETT gp with PLMA, there was a lower incidence of
sorethroat than with ETT gp (30% Vs 57%) (P < 0.05) and less difference
with SLIPA (30% Vs 49%) (P > 0.05).
              With  both SLA there was a significant reduction in operating
room time ( > 3 mts) (P <0.001).
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               The concluded that PLMA (reusable) and SLIPA (single use)
SLA’s were easy to use without requiring muscle relaxants  and less
operating room time compared to tracheal tube in day care laparoscopies.
PIPER SN, TRIEM JG, ROHM KD, MALECK WH,
SCHOLLHORN TA, BOLDT J, et al IN 2004.
           Assessed the practicality of PLMA when compared to ETT in 104
patients undergoing gynaecological laparoscopic surgery. TIVA was
performed by the same anaesthetist. They measured MAP, HR, circuit
pressure at 2 measurement points and incidence of coughing and
sorethroat.
           There was no difference between PLMA and ETT concerning
circuit pressure at any measurement points. At the end of anaesthesia
MAP (92 +/- 13 Vs 100  +/- 14 mmHg; P < 0.001) and HR (66 +/- 13 Vs
76 +/- 14 beats / mt; P <0.01) were lower in the PLMA gp compared to
ETT gp. 25 patients of ETT group coughed at the end of anaesthesia but
nobody in PLMA group (P < 0.00001). there was no difference with
regard to postoperative sorethroat. The insertion of PLMA was easier
compared to ETT (P < 0.05), but they found no significant difference
concerning insertion times.
            Finally they concluded that PLMA is a convenient and practical
approach for anaesthesia in patients undergoing laparoscopic surgery.
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GIUSEPEE NATALINI MD, GABRIELLA LANZA MD,
ANTONIO ROSANO MD15, et al IN 2002.
             Compared the frequency of airway seal and sorethroat with
PLMA and std. LMA in 60 adults, ASA I, II & III patients undergoing
lapraoscopic surgery under GA with controlled ventilation (Tidal volume
7ml/Kg, PEEP – 10 cm  H2O)
              HR, BP, inspiratory and expiratory tidal volume, airway
pressure, EtCO2 and  Sp  O2 were recorded. Leak fraction was calculated
as the difference between inspiratory and expiratory tidal volume divided
by inspiratory tidal volume. Postoperative sorethroat frequency was
scored in the recovery room (early) and 1 week after surgery (Late).
               Leak fraction was 7 + 32% with LMA and 7 + 4% with PLMA
(P = 0.731). Frequency of sorethroat is mild in 13% and 10% of patients
with LMA and PLMA respectively during the recovery room stay.
G.NATALINI, M.E. FRANCESCHETTI et al IN 2003
               They compared PLMA with LMA in obese patients. The study
was conducted on 60 obese patients randomized to receive mechanical
ventilation through PLMA or LMA. Airway cuffs were inflated to 60cm
H2O. Controlled ventilation with 10cm H2o of PEEP with applied. If leak
fraction was > 15% intra cuff volume needed to be increased in 45% of
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patients in LMA group compared to 13% in PLMA group. Leak fraction
in PLMA group was 6% which was comparable to tracheal group.
            Hence they concluded that PLMA was a better airway device for
morbidly obese patients compared to LMA.
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DETAILS OF STUDY
1. OFFICIAL TITLE
“Prospective, randomised comparison study of clinical
performance of two supraglottic airways, PROSEAL LMA and I-GEL in
elective surgeries”.
2. AIMS & OBJECTIVES
To compare the clinical performance of two supraglottic airways,
PROSEAL LMA and I-GEL in elective surgeries”.
3. STUDY DESIGN
Prospective, randomized, single blinded(subject), case control
study
4. STUDY TYPE  Interventional
5. STUDY SETTING AND POPULATION:
After obtaining institutional ethical committee clearance and
patients written informed consent, the study was carried out in TOT,
Institute of  Obstetrics and Gyaecology, Egmore, Chennai, from may
2010 to July 2010.
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The Study was conducted in 60 female patients in the age group of
18 years and above belonging to ASA I and II posted for elective
gynaecological surgeries.
6.  INCLUSION CRITERIA:
1. Age : 18 Years and above
2. Weight : BMI < 30 Kg/m2
3. ASA :  I & II
4. Surgery : Elective
5. Mouth Opening  : > 3cm
7.  EXCLUSION CRITERIA:
? Emergency Surgeries
? Age < 18
? Mouth opening < 3cm
? BMI > 30 Kg /M2
? Pregnant Female
? H/O. GERD
? Surgery involving upper GIT
? Poor lung compliance such as pulmonary fibrosis.
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8.  MATERIALS REQUIRED
? Proseal lma size 3
? I gel size 3
? 20ml syringe
? Lubricant jelly
? Drugs: Glycopyrolate, fortwin, propofol, midazolem, atracuriam,
isoflourane, neostigmine, ranitidine, metaclopromide.
? Monitors: ECG, Pulse Oximeter, NIBP, Capnography.
9.  STUDY OUTCOME
1. EASE OF INSERTION
Easy insertion(E):  Defined as no resistance to insertion in the
pharynx in a single attempt
Difficult insertion(D):  Defined as the one in which there was
resistance to insertion (or) more than one attempts was required
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2. NO OF INSERTION ATTEMPTS
Insertion of the laryngeal mask followed a strict protocol, upto 3
attempts were made to insert the mask and the number of attempts
required was recorded.  An attempt was defined as one passage of the
laryngeal mask into the oropharynx only.  If unsuccessful after three
attempts, the procedure abandoned.
3. TIME TAKEN FOR INSERTION
It was measured from proseal LMA  or igel inserted into the patient
oral cavity until conformation of the proper positioning of the airway.
4. HAEMODYNAMIC RESPONSES
The patient’s pulse rate and blood pressure were recorded just
before insertion and one minute and five minutes after the initiation of
insertion attempts.
5. BLOOD STAINING OF DEVICES
At the end of the surgery the laryngeal mask removed, when the
patient swallowing reflexes had returned and they could follow
commands.  The presence or absence of blood on the mask was noted.
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6. INCIDENCE OF COMPLICATIONS
The patients were asked whether they had a sore throat after
removal  of  LMA.   The  patients  also  carefully  monitored  whether  they
have any bronchospasm or laryngospasm.
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METHODOLOGY
Ethical committee approval
Patient satisfying inclusion criteria
Informed consent obtained
Randomization by closed envelope method
I GEL group- PLMA group
Premedication – inj. Glycopyrrolate 0.2mg + inj.Fortwin 30mg
Inj. Ranitidine 50mg + inj. Metaclopromide iv given.
HR, BP Measured
Preoxygenation for 3min
Induction : inj. Propofol 2mg /Kg + inj Atracurium 0.5mg /Kg
Pre insertion BP, HR measured
Insertion
Measurement of outcome : Ease of insertion , Time taken for insertion ,
No. of insertion attempts, Haemo dynamic response ,Blood staining of
devices, Incidence  of complication
Surgery proceded with maintenance of Anaeshesia with N2O / O2
mixture 2:1 +Iso fluorane 1MAC
After Surgery  patient
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reversed with inj. Neostigmine 50micro gram/kg + inj. Glycopyrrolate 10
micro gram /kg
Airway removed after oral suctioning
Data compilation
Statistical Analysis
Conclusion
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CONDUCT OF STUDY
The patients who had come for gynaecological surgery, screened
for comorbid illness and difficult airway.  Age, height, weight and BMI
were assessed.  If patients satisfied inclusion criteria, informed consent
was obtained and the patients were randamised into two groups using
closed envelope technique as proseal LMA group (P) and Igel group(I).
After the patient was shifted inside the operation room, intravenous
access gained.  ECG monitor, pulsoximeter and non invasive blood
pressure monitor were connected.  Preoperative BP, Heart rate were
recorded.
PREMEDICATION
Patient was premedicated with inj. Glycopyrrolate 0.2 mg, inj.
Fortwine 0.5 mg/kg, inj. Ranitidine 50 mg and inj. Metaclopramide 10
mg.
PREOXYGENATION
Patient preoxygenated with 100% O2 for 3 minutes.
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INDUCTION
Patient was induced with inj. Propofol 2mg/kg and inj. Atracurium
0.5mg/kg.  Patient was mask ventilated for 3 minutes.  Pre insertion BP,
Heart rate were recorded.
INSERTION
‘P’ Group
Size 3 proseal LMA was inserted in sniffing position by using
Index finger insertion technique.  Cuff was inflated with 20ml of room air
to the manufacturer recommended cuff pressure of 60cm H2O before
anaesthetic circuit was connected and patients lung ventilated.  Position
of PLMA was confirmed by
1. Bilateral chest movement
2. Square EtCO2 waveform
3. Absence of leak
With the PLMA, we filled the proximal 3cm of the drain tube with
the water soluble lubricant jelly.  If a gas bubble rose through the jelly
during inspiration indicating a gas leak into the oesophagus.  We
corrected the position of  PLMA and repeated the test until no bubble
appeared.
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‘I’ Group
Size 3 Igel was inserted in sniffing position. Position of Igel was
confirmed by
1. Bilateral chest movement
2. Square EtCO2 waveform
3. Absence of leak
PARAMETERS OBSERVED
1. Ease of insertion
2. No. of insertion attempts
3. Time taken for insertion
4. Hemodynamic responses
5. Blood staining of devices
6. Incidence of complications
MAINTANENCE OF ANAESTHESIA
                   Anaesthesia maintained with N20:O2 at 2:1 ratio and 1 MAC
of isoflurane.  Muscle relaxant was maintained with inj. Atracurium.  Post
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insertion BP, HR were recorded at 1 min and 5 minutes after insertion of
supraglottic airways.  Ryles tube was inserted through drainage tube.
Gynaecologist was requested to initiate the surgical procedure.
REVERSAL & EXTUBATION
After completion of surgery and adequate neuromuscular recovery,
patient was reversed with inj. Neostigmine 50 microgram/kg, inj.
Glycopyrrolate 0.4 mg/kg.  Suctioning of gastric content through ryles
tube was done.  After thorough oral suction, cuff was deflated and
supraglottic airways were removed.
Blood staining in the airway devices, cough, laryngospasm/stridor,
sorethroat and need for airway intervention during emergence from
anaesthesia were recorded.
Once the recovery was found adequate, the patient was shifted to
post operative ward and patients were interviewed for next 24 hours
regarding sore throat.
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OBSERVATION AND RESULTS
This prospective randomized comparative single blinded   case
control study of clinical performance of two supraglottic airway devices,
IGEL AND PROSEAL  LMA in 60 adult  women, ASA I AND II,  aged
18 years and above undergoing elective gynaecologic surgery . All data
were collected, tabulated and expressed as mean +/? standard deviation .
Appropriate statistical analysis was conducted. All quantitative data were
compared using chi-square test. P values were calculated for all test. A p
values 0 to 0.01 was considered as 1 % significant , 0.011 to 0.05 was
considered 5% significant , and >0.05 was considered as not significant.
The summated results represented below.
Table :1 Demographic profile : age
Group N0 : Mean SD P value
I GEL 30 31.20 9.353 0.460
PROSEAL 30 29.47 8.681 Not significant
The  mean  age  of  group  IGEL   is  31.20  and  group  PROSEAL  is
29.47.The data statistically not significant (p >0.05) and this both groups
are comparable in terms of age.
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Table  2: Demographic profile : BMI
Group N0 : Mean SD P value
I GEL 30 21.54 2.0698 0.530
PROSEAL 30 21.25 1.4323 Not significant
The mean BMI of group IGEL  is 21.54 and group PROSEAL is
21.25.The data statistically not significant (p >0.05) and this both groups
are comparable in terms of BMI.
Table 3 : Ease of insertion
Group NO; Easy Difficult P value
NO % NO % P= 0.038
SignificantI GEL 30 28 93.3 2 6.7
PROSEAL 30 22 73.3 8 26.7
By using I GEL , 28 cases were inserted easily and 2 cases were
inserted with difficulty .By using PROSEAL LMA 22cases were inserted
easily  and 8 cases were inserted with  difficulty.
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 Qualitative data values are compared by chi-square test. Statistical
analysis reveals P value is 0.038 which is significant at 5% level.
Table:4  No of attempts
IGEL insertion was successful in 28/30 in first attempt while 2
patients required second attempt   PROSEAL LMA insertion  was
successful in 24/30 in first attempt while 6 patients required second
attempt . statistical analysis reveals P value of 0.129 .the two groups are
statistically insignificant in  no of attempts(P>0.05)
Group No Success in
P ValueIst
Attempt
IInd
Attempt
IIIrd
attempt
I JEL 30 28 2 - P= 0.12
PROSEAL 30 24 6 NON
SIGNIFICANT
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Table 5; Time taken for insertion
Group NO Mean SD P value
I GEL 30 16.20 5.327 P= 0.000
Proseal LMA 30 25.20 5.162 P value < .001
Time taken for insertion with I GEL is 16.20 seconds and
PROSEAL  LMA  is  25.20  seconds.  Student  t  test   reveals  P  value  of
0.000(p < 0.001) which is significant at 1% level.
Table 6; Blood staining  of devices.
Group No
Blood Staining
P ValueYes No
I GEL 30 2 28 P=0.038
SIGNIFICANT
PRO SEAL 30 8 22
             Blood  staining  the  airway  device  noted  after  removal  of  the
device  indicates airway trauma. It occurred in 2/30 cases with I GEL,
8/30  cases  with  PROSEAL  LMA.  Chi  –square  test  reveals  p  value  of
0.038 which significant at 5% level. Hence  the incidence of airway
trauma is low with I GEL.
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Table No:7:  Incidence of Complications
Group No Yes No P Value
Sore Throat I GEL 30 - 30 P=0.150
NOT
SIGNIFICANT
PRO
SEAL
30 2 28
Group No Yes No P Value
Bronchospasm
Laryngospasm
Regurgitation
I GEL 30 - 30 P=1.00
NOT
SIGNIFICANT
PRO
SEAL
30 - 30
Intra & Post Operatively following complications were assessed. 1)
Bronchospasm 2) Laryngospasm 3) Sore Throat 4) Regurgitation. Sore
Throat assessed for 24hrs Post Operatively.
Sore Throat occurred in 2/30 cases with PRO SEAL LMA and no
sore  throat  with  I  GEL.  Statistical  analysis  reveals  P  Value  of  0.150
which is Not Significant.
Laryngospasm, Bronchospasm & Regurgitation does not occur
with both the groups. Stastical analysis reveals P Value of 1.000 which is
Not Significant. Hence incidence of complications is same with both
groups.
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Table:8: Haemodynamic Response
 Heart Rate
Group No Mean SD P Value
Pre
Insertion
I GEL 30 89 10.252 P=0.073
Not Significant
PRO
SEAL
30 83.47 13.038
Post
Insertion
after 1
min
I GEL 30 95.43 10.311 P=0.353
Not SignificantPRO
SEAL
30 92.60 12.968
Post
Insertion
after 5
min
I GEL 30 93.67 10.672 P=0.527
Not Significant
PRO
SEAL
30 91.73 12.774
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Systolic Blood Pressure
Group No Mean SD P Value
Pre Insertion I GEL 30 122.40 12.036 P=0.790
Not Significant
PRO
SEAL
30 121.63 10.128
Post Insertion
after 1 min
I GEL 30 122.97 12.019 P=0.382
Not Significant
PRO
SEAL
30 119.83 15.324
Post Insertion
after 5 min
I GEL 30 118.60 13.903 P=0.799
Not SignificantPRO
SEAL
30 119.50 13.292
Diastolic Blood Pressure
Group No Mean SD P Value
Pre
Insertion
I GEL 30 80.93 8.416 P=0.817
Not
SignificantPRO SEAL 30 80.50 5.782
Post
Insertion
after 1 min
I GEL 30 82.40 10.388 P=0.191
Not
SignificantPRO SEAL 30 77.43 17.751
Post
Insertion
after 5 min
I GEL 30 77.23 12.356 P=0.313
Not
SignificantPRO SEAL 30 80.47 12.272
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Mean Arterial Pressure
Group No Mean SD P Value
Pre Insertion I GEL 30 94.27 8.702 P=0.906
Not
SignificantPRO
SEAL
30 94.03 6.312
Post Insertion
after 1 min
I GEL 30 95.63 10.620 P=0.344
Not
SignificantPRO
SEAL
30 92.80 12.310
Post Insertion
after 5 min
I GEL 30 90.67 12.347 P=0.419
Not
SignificantPRO
SEAL
30 93.23 12.054
Heart rate, Blood Pressure were measured preoperatively before
insertion of airway devices and 1 min & 5 min after insertion. The actual
value are documented in the tabular column.
Heart Rate
Mean Preinsertion Heart rate with I Gel Group is 89 and Pro Seal
Group is 83.47. Mean Heart rate 1min after insertion with I Gel group is
95.4 and Pro Seal group is 92.6. Mean Heart Rate 5min after insertion
with I Gel group is 93.6 and Pro Seal group is 98.7.
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Statistical  analysis reveals P Values of Pre insertion heart rate, Heart rate
1min after insertion & Heart rate 5min after insertion was 0.073, 0.353 &
0.527 respectively. These P Values are Statistically  Not Significant.
Blood Pressure
                        P values of pre insertion systolic, diastolic, mean arterial
pressure were 0.790, 0.817, 0.906 respectively. P values of systolic,
diastolic, mean arterial pressures after 1 minute of insertion  were
0.382,0.197,0.344 respectively. P values of systolic diastolic mean
arterial pressure after 5 mintues of insertion were 0.799, 0.313, 0.419.
respectively. These p values are statistically insignifigant.
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DISCUSSION
             The Pro Seal LMA provides an acceptable way to maintain a
clear airway and provide positive pressure ventilation. It is also
associated with reduced risk of gastric insufflations, Regurgitation &
aspiration of gastric contents.
I Gel also provides patent airway during positive pressure
ventilation. It is also reduces the risk of gastric insufflations,
Regurgitation & aspiration of gastric contents.
This study was designed to compare clinical performance of this
two Supraglottic airway devices I Gel & Pro Seal LMA. This study was
conducted in 60 adult Women, ASA I & II, aged 18yrs & above
undergoing elective Gynaecological surgeries.
1. EASE OF INSERTION
Ishwer singh and the Monika Gupta1 compared IGEL and PLMA
in 60 patients. They  found ease of insertion was more with IGEL (29/30)
then with LMA Proseal (23/30) which was statistically significant.
In my study the ease of insertion was more with IGEL (29/30) then
with proseal LMA (22/30) P value is 0.038 which was statistically
significant at 5% level.
55
Levitan & Kinkle2 presumed  that  on  insertion  of  LMA  with
inflatable mask, the deflated leading edge of the mask can catch the edge
of the epiglottis & cause it to downfold or impede proper placement
beneath the tongue. Brimacombe and colleagues5 presumed that the
difficulties by larger cuff impeding digital intraoral positioning and
propulsion into the pharynx. The lack of back plate making cuff more
likely to fold over at the back of the mouth and the need for more precise
tip positioning to prevent air leaks up the drainage tube.
The finding of my study was in concurrence with the above data.
So IGEL is easier to insert as compare to proseal LMA.
2. NUMBER OF ATTEMPTS
Ishwar singh and Monika Gupta1 compared IGEL and proseal
LMA in 60 patients they found first attempt success rate with IGEL
(30/30) (100%) higher then with proseal LMA (28/30) (93.3) P value is <
0.05 so statistically insignificant.
In my study the first attempts success rate with IGEL was (28/30)
(93.3%) with proseal LMA was (24/30) (80%) P value is 0.129 (P>0.05)
this value or statistically insignificant.
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The finding of my study was in concurrence with the above data.
So  number  of  attempt  require  for  IGEL  was  fewer  than  that  of  proseal
LMA.
3. TIME TAKEN FOR INSERTION
J.J. Gatward & T.M. Cook evaluated the size 4 IGEL airway in one
hundred non paralyzed patient. In this study they found mean insertion
time with IGEL was 15 sec.
In my study mean insertion time with IGEL was 16.2 sec, with
proseal LMA was 25.2 sec P value is 0.000 which was significant at 1%
level. The finding of study was in concurrence with above data. So
insertion time with IGEL was shorter than proseal LMA.
4. HAEMODYNAMIC RESPONSE
SHIN  WJ,  &  cheyng.  YS17 compared IGEL proseal LMA and
classic LMA in elective surgery. They assessed haemodynamic response.
In this study they found there is no difference in heamodynamic
deference between IGEL, proseal LMA and classic LMA.
In my study also there is no difference in heamodynamic response
between IGEL and proseal LMA.
The finding of my study was in concurrence with above data.
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5. BLOOD STAINING OF DEVICE
In Ishwar singh and Monika Gupta1 study  blood  staining  of  the
devices  with  IGEL  was  1/30,  with  proseal  LMA  was  6/30  P  value  is  >
0.05 in my study blood staining of the devices with IGEL was 2/30 with
proseal LMA was 8/30 P value is 0.038 which is statistically significant
at 5% level.
In both study blood staining of devices with IGEL was lesser than
proseal LMA so airway trauma was less with IGEL than proseal LMA.
6. INCIDENCE OF COMPLICATION
In Ishwar singh and Monika Gupta1 study there was no incidence
of sorethroat, bronchospasm, laryngospasm, Regurgitation in both
groups.
But in my study there was a incidence of sorethroat in 2 cases with
proseal LMA. No incidence of bronchospasm, laryngosmpasm,
Regurgitaion with proseal LMA in IGEAL group there was no incidence
of sorethroat, bronchospasm, laryngospasm, Regurgitation P value of
sorethroat was 0.150 which was statistically not significant.
So incidence of complication with IGEL was comparatively less
but statistically not significant.
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SUMMARY
The Prospective Randomized comparative single blinded case
control study of clinical performance of two  Supraglottic airway devises
IGel & Pro Seal LMA in 60 adult women, ASA I & II, aged 18 and above
undergoing elective Gynaecological surgeries.
The conclusion deduced from the study are:
1) There were no significant difference between the two groups in
demographic data
2) Ease of insertion of  I Gel was better than that of Pro Seal LMA
which is Statistically Significant at 5% level (P=0.038)
3) Number of attempts required for successful placement for I Gel were
fewer than that of Pro Seal LMA but Not Statistically Significant.
4) Time taken for insertion of I Gel was lesser than Pro Seal LMA
which is Statistically Significant at 1% level.
5) There is No Significant Haemodynamic changes between I Gel &
Pro Seal groups.
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6) Blood staining of the devices with I Gel was fewer than Pro Seal
LMA which is Statistically Significant at 5% level. So airway
trauma was few with I Gel compared to Pro Seal LMA.
7) Incidence of  Sore Throat was few with Pro Seal LMA but Sore
Throat did not occur in I Gel. The other complications like
Bronchospasm, Laryngospasm & Regurgitation did not occur in
both groups.
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CONCLUSION
                I Gel is a cheap and effective device which is easier to insert
than Pro Seal LMA. It has other potential advantages like rapid
placement, less blood staining, less airway trauma than Pro Seal LMA. So
I Gel is a useful alternative Supraglottic device to Proseal LMA.
61
NUMBER OF ATTEMPTS
0
5
10
15
20
25
30
Ist
attempt
Iind
attempt
I Gel
Pro Seal
62
EASE OF INSERTION
0
5
10
15
20
25
30
Easy Difficult
I Gel
Pro Seal
63
BLOOD STAINING OF DEVICE
0
5
10
15
20
25
30
Yes No
I Gel
Pro Seal
64
TIME TAKEN FOR INSERTION
0
5
10
15
20
25
30
I Gel Pro Seal
Seconds
65
INCIDENCE OF SORE THROAT
0
5
10
15
20
25
30
Yes No
I Gel
Pro Seal
66
HEART RATE
67
  SYSTOLIC BLOOD PRESSURE
68
DIASTOLIC BLOOD PRESSURE
74
75
76
77
78
79
80
81
82
83
Pre
Insertion
Post 1min Post 5min
I Gel
Pro Seal
69
MEAN ARTERIAL PRESSURE
88
89
90
91
92
93
94
95
96
Pre
Insertion
Post 1min Post 5min
I Gel
Pro Seal
70
DEMOGRAPHIC PROFILE: AGE
28.5
29
29.5
30
30.5
31
31.5
I Gel Pro Seal
Mean
71
DEMOGRAPHIC PROFILE: BMI
21.1
21.15
21.2
21.25
21.3
21.35
21.4
21.45
21.5
21.55
I Gel Pro
Seal
Me…
72
BIBLIOGRAPHY
1. Ishwar singh and Monika Gupta (India Journal of Anaesthesia
2009;53(3);302-305) Comparison of Clinical Performance of I –
Gel TM with LMA – Proseal TM in Elective Surgeries.
2. Levitan RM and Kinkle WC. Initial anatomic investigations of the
I-gel airway: a novel supraglottic airway without inflatable cuff.
Anaesthesia 2005;1022-1026.
3. Brain AI, Verghese C, Strube PJ. The LMA ‘ProSeal’ – a laryngeal
mask with an oesophageal vent. Br J Anaesth 2000;84:650 – 4.
4. Shimbori H, Ono K, Miwa T, Morimura N, Noguchi M Hiroki K,
Comparison of the LMA – Proseal and LMA classic in children. Br
J Anaesth 2004;93:             528-31.
5. Brimacombe J, Keller C. The ProSeal laryngeal mask airway: a
randomized, crossover study with the standard laryngeal mask
airway in paralyzed, anesthetized patients. Anesthesiology,
2000;93:104-9.
6. Brimacombe J, Keller C, Fullekrug B, et al. a multicenter study
comparing the Proseal and Classic laryngeal mask airway in
anesthetized, nonparalyzed patients. Anesthesiology 2002;96:289-
95.
73
7. J.  Soar.  The  I-gel  supraglottic  airway  and  resuscitation  –  some
initial thoughts. J Resuscitation 2007;02:01211.
8. Gabbot D, R Beringer. The I-gel supraglottic airway:A potential
role for resuscitation? Resuscitation 2007; 73: 161-164.
9. Proseal LMA Instructions Manual, the Laryngeal Mask Company
Ltd, P.O. Box No. 23620, Nicosia, Cyprus.
10. Rashid Khan, Mohammed Maroof. Supraglottic airway devices.
Airway management 2007;12:122-127
11. J.Roger Maltby, Michael T. Beriault, neil C. Watson, David J.
Liepect. LMA – classic and LMA – Proseal are effective
alternatives to Endotracheal intubation for Gynaecological
Laparoscopy. Candadian Journal of Anaesthesia 50:71-77(2003)
12. Donald M. Miller, Luigi Camporota. Advantages of Proseal and
SLIPA airways over Tracheal Tube for Gynaecological
Laparoscopy. Canadian Journal of Anaesthesia 53:188-193(2006)
13. Hohlrieder, Brimacombe. Postoperative airway morbidity is lower
for PLMA than Endotracheal tube in females undergoing Breast
and Gynaecological surgery. British Journal of Anaesthesia 2007,
October;99:576-80.
74
14. Miller DM, Camporota L. Advantages of Proseal LMA and SLIPA
over Tracheal tube for Gynaecological Laparoscopy. Canadian
Journal of Anaesthesia 2006 February;53:188-93.
15. Giuseppa Natalini, Gabriella Lanza, Antonio Rosano, Standard
Laryngeal Mask Airway and LMA – Proseal during Laparoscopic
surgery. Journal of Critical Anaesthesia, Vlo. 15, issue 6, Page 428
– 432 (September 2003).
16. Study of airway management using PLMA compared with
Tracheal tube in 100 patients. Find – health – articles.com.
Research article summary (Published 30th August 2007)
17. Shin  WJ,  Cheong  YS.  Yang  HS  compared  I-GEL,  Proseal  LMA
and Classical LMA in Anaesthetised patients. European journal of
anaesthesiology 2009 Nov 12
75
PROFORMA
AIRWAY DEVICE USED : …………………………………………
NAME :
AGE :
IP No :
Wt : Ht : BMI :
Diagnosis :
Surgical Procedure Done :
PRE OPERATIVE ASSESSMENT
A. HISTORY
Co morbid illness and treatment details :
Effort Tolerance : …………… METS
H/O any documented difficult Airway :
H/O Previous Surgeries
GENERAL EXAMINATION
Anemia : Jaundice :
BP           : Pulse        :
CVS         : RS       :
a. AIRWAY EXAMINATION
? Mallampatti Classification :
? Neck Flexion :
? Neck extension :
? Inter Incisor Distance : ……………………….. cm
? Thyro Mental distance : …………………………… cm
? Upper Lip Bite Test :
76
? Denture : YES / NO
? If yes it is removable  / fixed :
? Buck teeth :
? Loose teeth :
? Absent teeth :
D.  MEASURES OF STUDY OUTCOMES :
1.  Ease of Insertion :
EASY DIFFICULT
2.  No. of  Insertion attempts.
3. Time taken for Insertion.
4. Haemodynamic response.
PRE INSERTION POST INSERTION
After 1
minutes
After  5
minutes
Blood
Pressur
e
SY
S
DI
A
MEA
N
SY
S
DI
A
MEA
N
SY
S
DI
A
MEA
N
Heart
Rate
5. Blood staining of device after removal Yes / No
6. Incidence of Complication :
B  - Bronchospasm Yes / No
L  - Laryngospasm. Yes / No
S - Sorethroat Yes / No
R  - Regurgitation Yes / No
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                     ABBREVIATION
LMA – Laryngeal mask airway
PLMA – Proseal Laryngeal mask airway
DT – Drainage tube
IPPV – Intermittent positive pressure ventilation
ID – Internal diameter
ETT – Endo tracheal tube
BMI – Body mass index
NIBP – Non invasive blood pressure
ECG – Electro cardiogram
EtCo2 – End tidal Co2
SD – Standard deviation
SLIPA – Streamlined liner of the Pharyngeal airway
PATIENT CONSENT FORM
STUDY TITLE: Prospective, randomiscd comparison study of
clinical performance of two supraglottic ainvays, PROSEAL LMA
and L-GEL in elective surgeries.
STUDY CENTRE : Department of Anaesihesiology, Institute of
Obstetrics and Gynecology.
PARTICIPANT NAME :        AGE:         SEX:       LD.NO:
I confirm that I have understood the purpose of procedure for the
above study. I have the opportunity to ask the question and all my
questions and doubts have been answered to my stratification.
I have been explained about the possible complications that may
occur during the procedure. Like injury to throat changes in voice, I
understand that every precaution will be taken to prevent such as injury.
If it happen will be treated accordingly.  I have been informed that no
other 'major complication has been reported so far with use of airway
device PROSEAL LAM & I GEL
I understand that my participation in the study is voluntary and that
I am free to withdraw at any time without giving any reason.
I understand that investigator, regulatory authorities and the ethics
committee will not need my permission to look at my health records both
in respect to the current study -and any further research that may be
conducted  in  relation  to  it,  even  if  I  withdraw  fro  m  the  study.  I
understand that my identity will not be revealed in any information
released to third parties or published, unless as required the law. I agree
not to restrict the use of any data or results that arise from the study.
I  here  consent  to  participate  in  this  study  of  comparison  study  of
clinical performance of two supraglottic airways, PROSEAL LMA and
L-GEL in elective surgeries.
Time:
Date : Signature / Thumb impression of patient
Place: Patient Name:
Signature of the investigator  :  ____________________
Name of the investigator :  ____________________
ÍÂ ´ôÒ¾ø ÀÊÅõ
¬ö× ¦ºöÂôÀÎõ ¾¨ÄôÒ
ÁÂì¸õ ¦¸¡ÎôÀ¾üÌ ÀÂýÀÎò¾ôÀÎõ þÕ Å¨¸Â¡É
¦À¡Õð¸Ç¡É PROSEAL LMA, ÁüÚõ I-GEL ¸ÕÅ¢¸Ç¢ø ±ó¾
¸ÕÅ¢ ¯À§Â¡¸ôÀÎòÐÅ¾üÌ ±Ç¢¾¡¸ ¯ûÇÐ ±ýÀ¨¾
¸ñ¼È¢Ôõ ¬ö×.
¬Ã¡öîº¢  ¿¢¨ÄÂõ  : ÁÂì¸Å¢Âø Ð¨È
      «ÃÍ  Á¸ô§ÀÚ  ÁÕòÐÅÁ¨É
      ±ì§Á¡÷,  ¦ºý¨É.
ÀíÌ ¦ÀÚÀÅ¡¢ý ¦ÀÂ÷  :
ÀíÌ ¦ÀÚÀÅ¡¢ý ±ñ  :
À¡Ä¢Éõ     :
ÀíÌ ¦ÀÚÀÅ÷ þ¾¨É (  ) ÌÈ¢ì¸×õ.
§Á§Ä ÌÈ¢ôÀ¢¼ôÀð¼ÎûÇ ÁÕòÐÅ ¬öÅ¢ý Å¢ÅÃí¸û
±ÉìÌ Å¢Çì¸ôÀð¼Ð. ±ýÛ¨¼Â ºó§¾¸í¸¨Ç §¸ð¸×õ,
«¾ü¸¡É ¾Ìó¾ Å¢Çì¸í¨Ç ¦ÀÈ×õ Å¡öôÀÇ¢ì¸ôÀð¼Ð.
¿¡ý þùÅ¡öÅ¢ø ¾ýÉ¢î¨ºÂ¡¸ò¾¡ý Àí§¸ü¸¢§Èý.
±ó¾ ¸¡Ã½ò¾¢É¡§Ä¡ ±ó¾¸ð¼ò¾¢Öõ ±ó¾ ºð¼ º¢ì¸Öõ
¯ðÀ¼¡Áø ¿¡ý þùÅ¡öÅ¢ø þÕóÐ Å¢Ä¸¢ ¦¸¡ûÇÄ¡õ
±ýÚõ «È¢óÐ ¦¸¡ñ§¼ý.
þó¾  ¬ö× ºõÀó¾Á¡¸§Å¡,  þ¨¾ º¡÷ó¾ §ÁÖõ  ¬ö×
§Áü¦¸¡ûÙõ §À¡Ðõ þó¾ ¬öÅ¢ø ÀíÌ¦ÀÚõ ÁÕòÐÅ÷
±ýÛ¨¼Â ÁÕòÐÅ «È¢ì¨¸¸¨Ç À¡÷ôÀ¾üÌ ±ý «ÛÁ¾¢
§¾¨ÅÂ¢ø¨Ä ±É «È¢óÐ ¦¸¡û¸¢§Èý. ¿¡ý ¬öÅ¢ø þÕóÐ
Å¢Ä¸¢ ¦¸¡ñ¼¡Öõ þÐ ¦À¡ÕóÐõ ±É «È¢¸¢§Èý.
þó¾ ¬öÅ¢ý ãÄõ ¸¢¨¼ìÌõ ¾¸Åø¸¨ÇÔõ,
À¡¢§º¡¾¨É  ÓÊ×¸¨ÇÔõ  ÁüÚõ  º¢¸¢î¨º  ¦¾¡¼÷À¡É
¾¸Åø¸¨ÇÔõ ÁÕòÐÅ÷ §Áü¦¸¡ûÙõ ¬öÅ¢ø ÀÂýÀÎò¾¢ì
¦¸¡ûÇ×õ «¨¾ À¢ÃÍ¡¢ì¸×õ ±ý ÓØ ÁÉÐ¼ý
ºõÁ¾¢ì¸¢§Èý.
þó¾ ¬öÅ¢ø ¸ÕÅ¢¸¨Ç ÀÂýÀÎòÐõ§À¡Ð
¦¾¡ñ¨¼Â¢ø ¸¡Âõ, Á÷Úõ ÌÃÄ¢ø Á¡üÈõ ²üÀÎÅ¾üÌ
Å¡öôÒ¸û  ¯ûÇÐ  ±ýÚõ,  «¾üÌ  ¾ì¸  ¿¼ÅÊì¨¸
±Îì¸ôÀÎõ  ±ýÀ¨¾Ôõ  ÁÕòÐÅ÷  ãÄõ  «È¢óÐ  ¦¸¡ñÎ
¿¡ý þó¾ ¬öÅ¢ø ÀíÌ¦ÀÈ ÓØÁÉÐ¼ý ºõÁ¾¢ì¸¢§Èý.
§¿Ãõ:
¿¡û:
þ¼õ:        ¸ÄóÐ
¦¸¡ûÀÅ¡¢ý
¨¸§Ã¨¸ / ¨¸¦Â¡ôÀõ
       ¦ÀÂ÷
¬öÅ¡Ç¡¢ý ¨¸¦Â¡ôÀõ:
¦ÀÂ÷:
¬ö× ÌÈ¢ò¾¡É Å¢ÅÃõ
ÁÂì¸õ ¦¸¡ÎôÀ¾üÌ þÕÅ¨¸Â¡É ¸ÕÅ¢¸û PROSEAL
LMA ÁüÚõ IGEL ¸ÕÅ¢¸û ¯À§Â¡¸ôÀÎò¾ôÀÎ¸¢ÈÐ. þó¾
þÃñÎ ¸ÕÅ¢¸Ç¢ø ±ó¾ ¸ÕÅ¢ ¯À§Â¡¸ôÀÎòÐÅ¾üÌ ±Ç¢¾¡¸
¯ûÇÐ ±ýÀ¨¾ì ¸ñ¼È¢Â þó¾ ¬ö× ¦ºöÂôÀÎ¸¢ÈÐ. þó¾
¸ÕÅ¢¸¨Ç ¯À§Â¡¸ôÀÎòÐõ§À¡Ð ¦¾¡ñ¨¼Â¢ø ¸¡Âõ
ÁüÚõ ÌÃÄ¢ø Á¡üÈõ ²üÀÎÅ¾üÌ Å¡öôÒ¸û ¯ûÇÐ. «ôÀÊ
§¿÷ó¾¡ø «¾üÌ ¾ì¸ ¿¼ÅÊì¨¸ ±Îì¸ôÀÎõ. §ÁÖõ, þó¾
¸ÕÅ¢¸¨Ç ¯À§Â¡¸ôÀÎòÐÅ¾¡ø, ÀÂôÀÎÅ¾üÌÈ¢Â §ÅÚ
±ó¾ À¢ý Å¢¨Ç×¸Ùõ þø¨Ä. þó¾ Å¢ÅÃí¸¨Ç «È¢ó¾ ¿¡ý
§ÁüÌÈ¢Â ¬öÅ¢ø ÓØÁÉÐ¼ý Àí§¸ü¸ ºõÁ¾¢ì¸¢§Èý.
ÀíÌ ¦ÀÚÀÅ¡¢ý ¨¸¦Â¡ôÀõ
þ¼Ð ¨¸ ¸ð¨¼ Å¢Ãø §Ã¨¸
¦ÀÂ÷:
INFORMATION ON THE STUDY
General Anesthesia can be administered through supraglottic
airways.  Comparison  of  ease  of  insertion  of  two  supragottic  airways.
PROSEAL  LMA  and   IGEL  being  studied.  While  using  these  airways
there is chance of occurance of throat injury and hoarseness of voice. In
case of such orrurance it will be treated accordingly. I have been
informed that no other major complication has been reported so far with
use of airway device proseal LMA and IGEL. Knowing this information,
I consent to whole heartedly participate in the above study.
Patients Signature
Thumb Impression;
Name :
MASTER CHART
S.No Name Age Device BMI EOI NOA TTI (Sec)
HEART RATE BLOOD PRESSURE
Blood Stain
COMPLICATION
PRE INSERTION POST INSERTATION
BS LS ST RN
Pre Post 1 Min Post 5 Min Sys Dia Mean Sys Dia Mean Sys Dia Mean
1 RANI 30 IGEL 19.0 E 1 15 91 94 94 121 81 94 128 90 102 118 81 93 No No No No No
2 SHAHEENA 25 IGEL 25.0 E 1 18 96 101 90 123 78 93 130 82 98 123 70 87 No No No No No
3 KAVITHA 27 IGEL 20.0 E 1 20 86 91 93 122 82 95 121 91 101 108 74 85 No No No No No
4 AMUDHA 25 IGEL 22.1 E 1 20 94 100 85 128 86 100 133 94 107 133 99 110 No No No No No
5 B B JOHN 46 IGEL 22.1 E 1 20 60 67 72 124 83 96 129 82 97 115 82 93 No No No No No
6 VALLI 19 IGEL 21.4 D 2 26 91 94 95 119 74 89 107 64 78 116 62 80 Yes No No No No
7 ROSI 46 IGEL 23.1 E 1 20 85 90 77 127 85 99 106 70 82 98 60 72 No No No No No
8 BRINDA 37 IGEL 26.0 E 1 15 80 90 84 120 82 94 129 90 103 109 69 82 No No No No No
9 SITA 40 IGEL 21.3 E 1 15 90 96 91 110 85 93 120 89 99 136 92 106 No No No No No
10 SUMITRA 28 IGEL 22.9 E 1 15 80 85 86 111 78 89 116 84 94 110 70 83 No No No No No
11 PRIYA 24 IGEL 23.1 E 1 15 100 110 113 111 71 84 117 75 89 118 72 87 No No No No No
12 RAMANI 26 IGEL 17.7 E 1 15 120 126 124 140 90 106 146 96 112 150 92 111 No No No No No
13 KANAGA 21 IGEL 24.4 E 1 16 93 101 99 123 80 94 128 88 102 105 58 73 No No No No No
14 VENI 45 IGEL 21.4 E 1 15 101 106 88 110 88 95 114 80 91 97 67 77 No No No No No
15 CHANDRA 40 IGEL 20.0 E 1 15 80 85 81 146 74 98 109 73 85 110 76 87 No No No No No
16 THILAGA 26 IGEL 21.3 E 1 15 92 100 102 115 80 91 120 83 95 107 67 80 No No No No No
17 RAJAMMAL 35 IGEL 22.2 E 1 15 96 100 102 130 86 97 136 92 106 140 102 114 No No No No No
18 VALLI 20 IGEL 17.7 E 1 15 92 98 100 106 64 78 96 52 66 105 63 77 No No No No No
19 MAHESWAR 28 IGEL 20.0 E 1 15 92 100 104 102 60 74 109 72 84 116 80 92 No No No No No
20 INDUMATH 30 IGEL 23.1 E 1 14 82 85 86 149 105 119 126 80 95 120 76 90 No No No No No
21 GEETHA 41 IGEL 22.2 E 1 18 90 96 101 120 82 94 126 90 102 127 93 104 No No No No No
22 INDRA 46 IGEL 22.2 E 1 20 85 92 90 110 76 87 116 73 87 105 68 80 No No No No No
23 KARTHIKA 19 IGEL 20.4 E 1 12 72 78 82 120 84 96 126 88 100 130 86 100 No No No No No
24 ANANDHI 27 IGEL 24.4 D 2 25 82 92 96 110 76 84 124 86 98 130 90 103 Yes No No No No
25 RAMADEVI 19 IGEL 17.7 E 1 14 92 102 106 115 70 85 125 76 92 113 62 79 No No No No No
26 SHAHEENA 22 IGEL 22.2 E 1 13 96 101 93 140 85 103 146 92 110 120 70 86 No No No No No
27 VASANTHA 48 IGEL 22.2 E 1 12 86 96 95 140 84 102 120 76 90 130 85 100 No No No No No
28 SUNDARI 40 IGEL 20.0 E 1 13 92 97 91 124 85 98 110 74 86 98 70 79 No No No No No
29 KALLI 30 IGEL 21.3 E 1 13 92 100 101 136 90 105 146 98 114 145 93 110 No No No No No
30 MEENA 26 IGEL 20.0 E 1 12 82 90 89 120 84 96 130 92 104 126 88 100 No No No No No
S.No Name Age Device BMI EOI NOA TTI (Sec)
HEART RATE BLOOD PRESSURE
Blood Stain
COMPLICATION
PRE INSERTION POST INSERTATION
BS LS ST RN
Pre Post 1 Min Post 5 Min Sys Dia Mean Sys Dia Mean Sys Dia Mean
1 GOWRI 29 Proseal 21.3 E 1 27 79 91 79 123 84 97 128 91 103 136 98 110 Yes No No Yes No
2 CHINNAPO 46 Proseal 22.2 D 2 32 86 92 96 128 76 93 110 70 83 123 82 95 No No No No No
3 SHANTHI 49 Proseal 22.2 E 1 25 90 98 87 112 74 86 100 64 72 97 60 72 No No No No No
4 RAMAJAYA 19 Proseal 20.0 E 1 28 100 112 115 100 60 73 109 52 68 114 62 80 No No No No No
5 CHITRA 25 Proseal 21.4 E 1 25 112 122 126 116 80 92 107 72 83 104 65 78 No No No No No
6 KARPAGAM 43 Proseal 19.5 D 2 30 72 80 87 112 74 86 120 86 97 123 87 99 Yes No No No No
7 GRACE 20 Proseal 20.0 D 2 32 103 112 105 120 80 93 130 90 103 132 86 101 Yes No No No No
8 BHAVANI 41 Proseal 22.9 D 2 32 120 130 118 144 84 104 150 92 111 138 99 112 Yes No No No No
9 VALLI 43 Proseal 23.1 E 1 20 79 86 73 120 76 90 90 57 68 95 59 71 No No No No No
10 RANI 27 Proseal 19.5 E 1 25 78 88 92 110 86 94 94 78 83 106 83 90 Yes No No Yes No
11 RAJI 25 Proseal 20.8 E 1 22 65 75 78 124 83 96 120 60 80 106 58 74 No No No No No
12 SUDHA 26 Proseal 21.3 E 1 25 78 88 90 121 80 94 124 88 100 114 77 89 No No No No No
13 MEENA 19 Proseal 20.0 E 1 22 86 94 100 110 80 90 116 90 99 120 86 97 No No No No No
14 ANANDHI 36 Proseal 22.2 D 2 32 72 85 80 140 88 105 130 76 94 105 72 83 No No No No No
15 SAVITHA 27 Proseal 21.7 E 1 25 90 98 96 130 84 99 140 92 108 136 88 104 No No No No No
16 VALLI 19 Proseal 17.7 E 1 25 72 80 86 110 82 91 106 80 88 120 92 101 No No No No No
17 NEELAVEN 38 Proseal 22.2 E 1 25 78 87 89 120 86 97 130 90 101 130 96 107 No No No No No
18 SUGUNA 30 Proseal 20.0 D 2 35 78 92 96 120 84 96 130 92 104 136 90 105 Yes No No No No
19 KANNIMAR 30 Proseal 23.1 E 1 22 84 92 96 124 80 94 136 90 105 130 94 106 No No No No No
20 LAKSMI 28 Proseal 24.0 E 1 19 76 83 79 124 82 96 110 70 83 109 66 80 No No No No No
21 ARULMARY 23 Proseal 21.7 E 1 22 82 90 94 130 90 103 110 80 90 107 64 78 No No No No No
22 SUMATHY 30 Proseal 22.2 E 1 22 86 92 90 126 80 95 110 76 87 116 80 92 No No No No No
23 JENNIFER 22 Proseal 21.3 E 1 25 92 99 100 132 72 92 130 80 96 136 84 101 No No No No No
24 SUMATHY 28 Proseal 19.5 D 1 32 76 88 80 123 84 97 126 90 102 134 86 102 Yes No No No No
25 CHANDRA 24 Proseal 21.7 E 1 19 65 77 74 116 82 93 107 74 84 114 80 91 No No No No No
26 SARALA 42 Proseal 22.2 E 1 22 79 89 84 140 82 101 146 92 110 136 84 101 No No No No No
27 AMUDHA 22 Proseal 20.0 D 1 24 66 72 79 110 80 90 116 86 96 106 74 84 No No No No No
28 KARPAGAM 25 Proseal 23.1 E 1 20 74 86 85 120 84 96 130 90 103 130 96 107 Yes No No No No
29 SELVI 22 Proseal 21.4 E 1 22 92 100 102 112 74 86 100 69 79 106 80 88 No No No No No
30 KAVITHA 26 Proseal 19.5 E 1 20 94 100 96 132 84 102 140 6 104 126 86 99 No No No No No
